Fatal hypersensitivity pneumonitis associated with docetaxel

Tumori

Volumn 99, Issue 3, 2013, Pages

  Gurram, Murali Krishna ^a   Pulivarthi, Swaroopa ^a   McGary, Carl T ^a  

^a UNIV OF MINNESOTA HOSP AND CLINIC   (United States)

Author keywords

Cancer; Chemotherapy; Docetaxel; Hypersensitivity; Pneumonitis; Respiratory failure

Indexed keywords

BRAIN NATRIURETIC PEPTIDE; CORTICOSTEROID; DOCETAXEL; LEVOFLOXACIN; MEPREDNISONE; PIPERACILLIN PLUS TAZOBACTAM; PREDNISONE; STEROID; VANCOMYCIN; ANTIINFECTIVE AGENT; ANTIINFLAMMATORY AGENT; ANTINEOPLASTIC AGENT; METHYLPREDNISOLONE; TAXOID;

ADULT; ALLERGIC PNEUMONITIS; ANTIBIOTIC THERAPY; ARTICLE; BREAST CANCER; BRONCHOSCOPY; CANCER PALLIATIVE THERAPY; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; CORTICOSTEROID THERAPY; DEATH; DETERIORATION; DIFFERENTIAL DIAGNOSIS; DISEASE COURSE; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG SUBSTITUTION; DRUG WITHDRAWAL; ECHOCARDIOGRAPHY; FATALITY; FEMALE; FROZEN SECTION; HISTOPATHOLOGY; HOSPITAL READMISSION; HUMAN; INTENSIVE CARE UNIT; INTERSTITIAL PNEUMONIA; LUNG BIOPSY; LUNG LAVAGE; MASTECTOMY; MEDICAL HISTORY; MIDDLE AGED; OUTCOME ASSESSMENT; RESPIRATORY FAILURE; SUPPORTIVE CARE; THORACOSCOPY; THORAX RADIOGRAPHY; URINARY TRACT INFECTION; ALVEOLITIS, EXTRINSIC ALLERGIC; BREAST NEOPLASMS; CHEMICALLY INDUCED; COMPLICATION; DRUG HYPERSENSITIVITY; IMMUNOLOGY; RESPIRATORY INSUFFICIENCY;

ALVEOLITIS, EXTRINSIC ALLERGIC; ANTI-BACTERIAL AGENTS; ANTI-INFLAMMATORY AGENTS; ANTINEOPLASTIC AGENTS; BREAST NEOPLASMS; DRUG HYPERSENSITIVITY; FATAL OUTCOME; FEMALE; HUMANS; LEVOFLOXACIN; MASTECTOMY, MODIFIED RADICAL; METHYLPREDNISOLONE; MIDDLE AGED; PREDNISONE; RESPIRATORY INSUFFICIENCY; TAXOIDS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84886076554     PISSN: 03008916     EISSN: 20382529     Source Type: Journal    
DOI: 10.1177/030089161309900325     Document Type: Article

References (17)

1. Alsamarai S, Charpidou AG, Matthay RA, Confeld D, Syrigos KN, Saif MW: Pneumonitis related to docetaxel: case report and review of the literature. In vivo, 23: 635-638, 1997.
2. Dunsford ML, Mead GM, Baterman AC, Cook T, Tung K: Severe pulmonary toxicity in patients treated with combination of docetaxel and gemcitabine for metastatic transitional cell carcinoma. Ann Oncol, 10: 943-947, 1999.
3. Karakan O, Eyuboglu FO, Akcay S, Ozylkan O: Acute interstitial pneumopathy associated with docetaxel hypersensitivity. Onkologie, 27: 563-565, 2004.
4. Read WL, Mortimer JE, Picus J: Severe interstitial pneumonitis associated with docetaxel administration. Cancer, 94: 847-853, 2002.
5. Wang GS, Yang KY, Perng RP: Life threatening hypersensitivity pneumonitis induced by docetaxel. Br J Cancer, 85: 1247-1250, 2001.
6. Semb KA, Aamdal S, Oian P: Capillary protein leak syndrome appears to explain fluid retention in cancer patient who receive docetaxel treatment. J Clin Oncol, 16: 3426-3432, 1998.
7. Piccart MJ, Klijn J, Paridaens R: Corticosteroids significantly delay the onset of docetaxel-induced fluid retention: final results of the randomized study of the European Organazation for Research and Treatment of Cancer Investigational Drug Branch for Breast Cancer. J Clin Oncol, 15: 3149-3155, 1997.
8. Merad M, Le Cesne A, Baldeyrou P, Mesurolle B, Le Chevalier T: Docetaxel and interstitial pulmonary injury. Ann Oncol, 8: 191-194, 1997.
9. Cooper JAD, White DA, Matthay RA: Drug-induced pulmonary disease. Part 1: cytotoxic drugs. Am Rev Respir Dis, 133: 321-340, 1986.
10. Nagata S, Ueda N, Yoshida Y, Matsuda H, Maehara Y: Severe interstitial pneumonitis associated with the administration of taxanes. J Infect Chemothe, 16: 340-344, 2010.
11. Chen YM, Shif JF, Perng RP: A randomizedtrial of different docetaxel schedules in non-small cell lung cancer patients who failed previous platinum-based chemotherapy. Chest, 129: 1031-1038, 2006.
12. Morris MJ, Santamauro J, Shia J, Schwartz L, Vander Els N, Kelly K, Scher H: Fatal respiratory failure associated with treatment of prostate cancer using docetaxel and estramustine. Urology, 60: 1111, 2002.
13. Mileshkin L, Prince HM, Rischin D, Zimet A: Severe interstitial pneumonitis following high-dose cyclosphosphamide, thiotepa and docetaxel: two case reports and a review of the literature. Bone Marrow Transplant, 27: 559-563, 2001.
14. Mauer AM, Masters GA, Haraf DJ, Hoffman PC, Watson SM, Golomb HM, Vokes EE: Phase I study of docetaxel with concomitant thoracic radiation therapy. J Clin Oncol, 16: 159-164, 1998.
15. Fujimori K, Yokoyama A, Kurita Y, Uni K, Saijo N: Paclitaxel- induced cell-mediated hypersensitivity pneumonitis. Diagnosis using leukocyte migration test, bronchoalveolar lavage and transbronchial lung biopsy. Oncology, 55: 340-344, 1998.
16. Leimgruber K, Negro R, Baier S, Moser B, Resch G, Sansone S, Adami M, Zanon P, Graiff C, Egarter-Vigl E, Wiedermann CJ: Fatal interstitial pneumonitis associated with docetaxel administration in a patient with hormone-refractory prostate cancer. Tumori, 92: 542-544, 2006.
17. Kuip E, Muller E: Fatal pneumonitis after treatment with docetaxel and trastuzumab. Neth J Med, 67: 237-239, 2009.